Enanta Pharmaceuticals (ENTA) Stock: Buy, Sell, or Hold?
ENTA - Enanta Pharmaceuticals, Inc
$12.96
0.12 (0.93%)
â˛
5d:
+9.09%
30d:
-8.02%
90d:
-10.68%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 16, 2026
Get Alerted When ENTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ENTA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ENTA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ENTA is currently trading at $12.96, which is considered fair relative to its 30-day fair value range of $12.31 to $13.72.
Technical Outlook: Technically, ENTA is showing sideways momentum. Immediate support is located at $11.64, while resistance sits at $13.45.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $21.83 (+68.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ENTA is showing sideways momentum. Immediate support is located at $11.64, while resistance sits at $13.45.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $21.83 (+68.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$12.31 -
$13.72
Company Quality Score
50/100
(HOLD)
Options IV Signal
58th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
73.8%
Protect Your Profits
Holding ENTA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 58th percentile)
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 68.5% below Wall St target ($21.83)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$12.31 -
$13.72
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$1.72
(13.2%)
Support & Resistance Levels
Support Level
$11.64
Resistance Level
$13.45
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.46
Wall Street Target
$21.83
(+68.5%)
Revenue Growth (YoY)
-21.6%
Earnings Growth (YoY)
-66.2%
Profit Margin
-96.9%
Share & Embed Analysis
Last updated: October 03, 2026 4:43 PM ET
Data refreshes hourly during market hours. Next update: 5:43 PM
Data refreshes hourly during market hours. Next update: 5:43 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$371 | 49 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
Advanced ENTA Option Strategies
Professional options setups generated by AI based on today's ENTA price and gamma walls.
